Survival time in Alzheimer’s disease
January 29 Wednesday, 2025 | Kurkinen M, Daly T (2024) Survival time in Alzheimer’s disease: an overlooked measure of safety and efficacy of disease-modifying therapies. Adv Clin Exp Med 33:1039-1043 https://advances.umw.edu.pl/en/ article/2024/33/10/1039/ was highlighted on the website of Wroclaw Medical University, as Editor-in-Chief’s Tuo Pick in 2024, and promoted on Facebook, LinkedIn, and X https://wroclaw-medical-university.shorthandstories.com/survival-time/ with podcast: https://wroclaw-medical-university.shorthandstories.com/survival-time/
The Year 2025 is Near
Washington, D.C., July 30, 2024 | Today the Senate unanimously passed bipartisan legislation that will renew the nation’s commitment to addressing the Alzheimer’s crisis — the NAPA Reauthorization Act (S. 133 / H.R. 619) and the Alzheimer’s Accountability and Investment Act (S. 134 / H.R. 620).https://www.alz.org/news/2024/senate-passes-napa-reauthorization-act
Francisco Lopera 1951-2024
Francisco Lopera (June 10, 1951 – September 10, 2024), a professor and neurologist at the University of Antioquia in Medellín, Colombia, identified and studied the world’s largest extended family with inherited Alzheimer dementia caused by the dominant E280A mutation in the PS1 gene. Pam Belluck “Francisco Lopera, Pioneer in Alzheimer’s Research, Dies at 73”. The New York Times, September 10, 2024Jennie Erin […]